We are live on ! Find out more
SCI

S&CO Inc Portfolio holdings

AUM $1.61B
1-Year Est. Return 21.39%
This Fund
S&P 500
This Quarter Est. Return
+7.84%
1 Year Est. Return
+21.39%
3 Year Est. Return
+58.88%
5 Year Est. Return
+84.19%
10 Year Est. Return
+267.05%
AUM
$1.42B
AUM Growth
+$116M
Cap. Flow
+$31.3M
Cap. Flow %
2.2%
Top 10 Hldgs %
38.27%
Holding
219
New
27
Increased
45
Reduced
60
Closed
9

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$9.69M
2
PYPL icon
PayPal
PYPL
+$5.46M
3
FMC icon
FMC
FMC
+$4.66M
4
PPLI
People Inc
PPLI
+$4.25M
5
AR icon
Antero Resources
AR
+$3.32M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$14.3M
2
AAPL icon
Apple
AAPL
+$5.37M
3
LBRDK icon
Liberty Broadband Class C
LBRDK
+$4.47M
4
CHTR icon
Charter Communications
CHTR
+$2.11M
5
PXD
Pioneer Natural Resource Co.
PXD
+$1.87M

Sector Composition

Rank Sector Weight
1 Healthcare 17.38%
2 Technology 17.25%
3 Materials 12.26%
4 Communication Services 9.41%
5 Financials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RSG icon
176
Republic Services
RSG
$66.7B
$335K 0.02%
1,750
– –
AVGO icon
177
Broadcom
AVGO
$1.82T
$331K 0.02%
2,500
– –
ABBV icon
178
AbbVie
ABBV
$454B
$319K 0.02%
1,754
– –
CATC
179
DELISTED
CAMBRIDGE BANCORP
CATC
$309K 0.02%
4,548
– –
VEA icon
180
Vanguard FTSE Developed Markets ETF
VEA
$227B
$308K 0.02%
6,150
– –
ITRI icon
181
Itron
ITRI
$3.76B
$305K 0.02%
3,300
– –
CI icon
182
Cigna
CI
$77B
$299K 0.02%
826
– –
IDXX icon
183
Idexx Laboratories
IDXX
$43.9B
$269K 0.02%
500
– –
AYI icon
184
Acuity Brands
AYI
$10.1B
$268K 0.02%
1,000
– –
ZWS icon
185
Zurn Elkay Water Solutions
ZWS
$8.14B
$267K 0.02%
8,000
– –
EMR icon
186
Emerson Electric
EMR
$83.6B
$258K 0.02%
2,280
– –
VOO icon
187
Vanguard S&P 500 ETF
VOO
$968B
$254K 0.02%
530
-80
-13% -$36.6K
HI
188
DELISTED
Hillenbrand
HI
$251K 0.02%
5,000
– –
SLB icon
189
SLB Ltd
SLB
$76.5B
$243K 0.02%
4,450
– –
CLH icon
190
Clean Harbors
CLH
$15.9B
$241K 0.02%
1,200
– –
AMGN icon
191
Amgen
AMGN
$203B
$237K 0.02%
834
– –
KNSL icon
192
Kinsale Capital Group
KNSL
$8.24B
$236K 0.02%
+450
New +$203K
NOC icon
193
Northrop Grumman
NOC
$77.8B
$235K 0.02%
492
– –
WM icon
194
Waste Management
WM
$95.5B
$234K 0.02%
+1,100
New +$216K
NKE icon
195
Nike
NKE
$62.5B
$227K 0.02%
2,420
– –
PAYX icon
196
Paychex
PAYX
$41.1B
$217K 0.02%
1,775
– –
CL icon
197
Colgate-Palmolive
CL
$73.6B
$216K 0.02%
+2,400
New +$203K
RRX icon
198
Regal Rexnord
RRX
$14B
$216K 0.02%
+1,200
New +$187K
PFG icon
199
Principal Financial Group
PFG
$24B
$215K 0.02%
+2,500
New +$201K
AOS icon
200
A.O. Smith
AOS
$8.61B
$214K 0.02%
+2,400
New +$198K
5 6 7
8
9

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
RC
Roundview Capital Princeton, New Jersey $1.61B AUM 16.92% 1-Year Est. Return
TLFA
True Link Financial Advisors San Francisco, California $1.62B AUM 8.33% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

S&CO Inc's Q1 2024 Portfolio in Review

As of Q1 2024, S&CO Inc held 219 positions worth $1.42B, up 8.9% from $1.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

S&CO Inc's Q1 2024 filing shows 27 new, 45 increased, 60 reduced and 9 closed positions. Its largest new stake was Illumina: 24,209 shares worth $3.23M. The largest sale was Bristol-Myers Squibb, an estimated $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Technology and Materials.

  • S&CO Inc's largest Q1 2024 buy was Illumina: 24,209 shares worth $3.23M.
  • S&CO Inc added most to UnitedHealth in Q1 2024, an estimated $9.69M increase.
  • S&CO Inc's biggest Q1 2024 reduction was Apple, cutting an estimated $5.37M.
  • S&CO Inc fully exited Bristol-Myers Squibb in Q1 2024, selling an estimated $14.3M.
  • S&CO Inc's ten largest holdings make up 38% of its $1.42B portfolio in Q1 2024.
  • S&CO Inc opened 27 new positions and closed 9 in Q1 2024.
  • S&CO Inc's portfolio value rose 8.9% quarter-over-quarter to $1.42B.

Based on S&CO Inc's 13F filing for Q1 2024, filed 9 May 2024.